Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

9.29
Delayed Data
As of 3:59pm ET
 +0.56 / +6.41%
Today’s Change
3.50
Today|||52-Week Range
10.06
+73.64%
Year-to-Date

Today’s Trading

Previous close8.73
Today’s open8.90
Day’s range8.89 - 9.51
Volume48,148
Average volume (3 months)20,786
Market cap$695.3M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-487.72%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
OFIXOrthofix Internation...-0.83-2.08%
IVCInvacare Corp-0.10-0.87%
RTIXRTI Surgical Inc+0.05+1.35%
CFMSConforMIS Inc-0.11-2.27%
Data as of 4:02pm ET, 03/23/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts


Search for Jobs